Cite
HARVARD Citation
Bauer, S. et al. (n.d.). 1662TiPVOYAGER: An open-label, randomised, phase III study of avapritinib vs regorafenib in patients (pts) with locally advanced (adv) metastatic or unresectable gastrointestinal stromal tumour (GIST). Annals of oncology. p. . [Online].